Cleveland Clinic, RIKEN, and IBM Cross 12,000-Atom Barrier in Heterogeneous Quantum-Classical Drug Binding Simulations
AI-summarised brief · reviewed before publication
A joint effort by Cleveland Clinic, RIKEN and IBM Quantum has performed the largest heterogeneous quantum‑classical (HQC) electronic‑structure simulation to date, modeling solvated protein‑ligand complexes of more than 12,000 atoms. The team linked two 156‑qubit IBM Heron r2 processors with three leading supercomputers, executing 21,006 circuits and collecting 3 billion measurement shots. Their Embedded Wavefunction (EWF) formalism partitions macromolecules into bounded atomic neighborhoods, reducing fragment‑construction cost from cubic to constant scaling. For fragments containing 13‑45 molecular orbitals, the new TrimSQD algorithm iteratively filters and merges configurations across GPU clusters before a final subspace diagonalization. An automated Prefect workflow coordinated IBM Quantum Runtime and the ROQ supercomputer, processing 608 million samples in 62.4 hours without human intervention. The work, detailed in an arXiv preprint, was funded by NSF, NIH, NEDO and Japan’s MEXT Fugaku program.
💡 Why It Matters
- · By breaking the 12,000‑atom barrier, the study shows quantum‑enhanced simulations can tackle realistic drug‑binding problems that were previously out of reach for classical methods.